Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Fast track – JSH2025 Tokyo: Current evidence and perspectives for hypertension management in Asia
  • Published:

Antihypertensive treatment effect of two dual therapies according to sodium sensitivity

Abstract

We investigated the blood pressure (BP) lowering efficacy of two dual antihypertensive therapies, the amlodipine/benazepril and benazepril/hydrochlorothiazide combinations, according to sodium sensitivity risk (SSR) as assessed by ambulatory BP monitoring (ABPM). In a multi-center, randomized, actively-controlled, parallel-group trial, patients with a clinic systolic/diastolic BP of 140 to 179/90 to 109 mmHg while on benazepril 10 mg daily monotherapy, received 24-week antihypertensive treatment with amlodipine/benazepril 5/10 mg (n = 213) or benazepril/hydrochlorothiazide 10/12.5 mg (n = 212). SSR was assessed with two 24-h ABPM parameters, BP dipper status at night and 24-h mean heart rate. The amlodipine/benazepril combination, compared with benazepril/hydrochlorothiazide combination, showed greater BP lowering effect in 304 patients with low/intermediate SSR, but smaller BP lowering effect in 121 patients with high SSR, with significant (P ≤ 0.046) interaction for 24-h, daytime and morning systolic BP. Indeed, in comparison with the benazepril/hydrochlorothiazide group, 24-h and daytime systolic BP reductions in the amlodipine/benazepril group were 4.19 and 5.17 mmHg, respectively, greater in patients with low/intermediate SSR, while morning systolic BP reductions was 10.8 mmHg smaller in patients with high SSR. Similar trends were observed for the other systolic BP measurements and diastolic BP measurements, although statistical significance was not attained (P ≥ 0.069). Sensitivity analysis in 367 patients with sustained hypertension was confirmatory. In conclusion, the antihypertensive treatment effect of the amlodipine/benazepril and benazepril/hydrochlorothiazide combinations was dependent on SSR as assessed by ABPM, with the former combination being more efficacious in patients with low/intermediate SSR, but less efficacious in patients with high SSR.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

Consent given by study participants did not include data sharing with third parties. Anonymized data can be made available to investigators for targeted research based on a motivated request to be addressed to the corresponding author via jiguangwang@rjh.com.cn.

References

  1. Huang L, Trieu K, Yoshimura S, Neal B, Woodward M, Campbell NRC, et al. Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials. BMJ. 2020;368:m315.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Suckling RJ, He FJ, Markandu ND, MacGregor GA. Modest salt reduction lowers blood pressure and albumin excretion in impaired glucose tolerance and type 2 diabetes mellitus: a randomized double-blind trial. Hypertension. 2016;67:1189–95.

    Article  CAS  PubMed  Google Scholar 

  3. Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41:1874–2071.

    Article  CAS  PubMed  Google Scholar 

  4. Vogt L, Marques FZ, Fujita T, Hoorn EJ, Danser AHJ. Novel mechanisms of salt-sensitive hypertension. Kidney Int. 2023;104:690–7.

    Article  CAS  PubMed  Google Scholar 

  5. Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481.

    Article  PubMed  Google Scholar 

  6. Schulz M, Krueger K, Schuessel K, Friedland K, Laufs U, Mueller WE, et al. Medication adherence and persistence according to different antihypertensive drug classes: a retrospective cohort study of 255,500 patients. Int J Cardiol. 2016;220:668–76.

    Article  PubMed  Google Scholar 

  7. Santos EM, Cunha LCC, Dias RSC, Cruz Diniz MC, Brito DJA, Teixeira TCS, et al. Dietary evaluation of sodium intake in patients with chronic kidney disease. Nutr Hosp. 2023;40:96–101.

    PubMed  Google Scholar 

  8. Huang QF, Cheng YB, Guo QH, Liu CY, Kang YY, Sheng CS, et al. Clinic and ambulatory blood pressure in relation to the interaction between plasma advanced glycation end products and sodium dietary intake and renal handling. Hypertens Res. 2022;45:665–74.

    Article  CAS  PubMed  Google Scholar 

  9. Kurzhagen JT, Titze S, Buschges-Seraphin B, Schiffer M, Schneider MP, Eckardt KU, et al. Spot urinary sodium in CKD patients: correlation with 24h-excretion and evaluation of commonly used prediction equations. BMC Nephrol. 2024;25:210.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Zhou E, Lei R, Tian X, Liu C, Guo J, Jin L, et al. Association between salt sensitivity of blood pressure and the risk of hypertension in a Chinese Tibetan population. J Clin Hypertens. 2023;25:453–62.

    Article  Google Scholar 

  11. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension. 1996;27:481–90.

    Article  CAS  PubMed  Google Scholar 

  12. Castiglioni P, Parati G, Brambilla L, Brambilla V, Gualerzi M, Di Rienzo M, et al. Detecting sodium-sensitivity in hypertensive patients: information from 24-hour ambulatory blood pressure monitoring. Hypertension. 2011;57:180–5.

    Article  CAS  PubMed  Google Scholar 

  13. Huang QF, Zhang D, Luo Y, Hu K, Wu Q, Qiu H, et al. Comparison of two single-pill dual combination antihypertensive therapies in Chinese patients: a randomized, controlled trial. BMC Med. 2024;22:28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Takahashi H, Saito K, Yakura N. Validation of Omron HEM-9200T, a home blood pressure monitoring device for the upper arm, according to the American National Standards Institute/Association for the Advancement of Medical Instrumentation/International Organization for Standardization 81060-2:2013 protocol. J Hum Hypertens. 2022;36:416–9.

    Article  PubMed  Google Scholar 

  16. Palatini P, Frigo G, Bertolo O, Roman E, Da Corta R, Winnicki M. Validation of the A&D TM-2430 device for ambulatory blood pressure monitoring and evaluation of performance according to subjects’ characteristics. Blood Press Monit. 1998;3:255–60.

    CAS  PubMed  Google Scholar 

  17. Ojji DB, Mayosi B, Francis V, Badri M, Cornelius V, Smythe W, et al. Comparison of dual therapies for lowering blood pressure in black Africans. N Engl J Med. 2019;380:2429–39.

    Article  CAS  PubMed  Google Scholar 

  18. Jamerson KA, Bakris GL, Weber MA. 24-hour ambulatory blood pressure in the ACCOMPLISH trial. N Engl J Med. 2010;363:98.

    Article  CAS  PubMed  Google Scholar 

  19. Fulvio MD. Inflammatory pathways of sulfonamide diuretics: insights into SLC12A Cl(-) symporters and additional targets. Cell Physiol Biochem. 2025;59:1–24.

    Article  CAS  PubMed  Google Scholar 

  20. Agarwal R, Verma A, Georgianos PI. Diuretics in patients with chronic kidney disease. Nat Rev Nephrol. 2025;21:264–78.

    Article  PubMed  Google Scholar 

  21. Polina I, Domondon M, Fox R, Sudarikova AV, Troncoso M, Vasileva VY, et al. Differential effects of low-dose sacubitril and/or valsartan on renal disease in salt-sensitive hypertension. Am J Physiol Ren Physiol. 2020;319:F63–F75.

    Article  CAS  Google Scholar 

  22. Yang C, Isaeva E, Shimada S, Kurth T, Stumpf M, Zheleznova NN, et al. Inhibition of mTORC2 promotes natriuresis in Dahl salt-sensitive rats via the decrease of NCC and ENaC activity. Am J Physiol Ren Physiol. 2024;327:F435–F49.

    Article  CAS  Google Scholar 

  23. Fujiwara T, Tomitani N, Kanegae H, Kario K. Comparative effects of valsartan plus either cilnidipine or hydrochlorothiazide on home morning blood pressure surge evaluated by information and communication technology-based nocturnal home blood pressure monitoring. J Clin Hypertens. 2018;20:159–67.

    Article  CAS  Google Scholar 

  24. Kondo K, Toh R, Ishida T, Mori K, Yasuda T, Hirata K. Comparison of telmisartan/amlodipine and telmisartan/hydrochlorothiazide in the treatment of Japanese patients with uncontrolled hypertension: the TAT-Kobe study. Blood Press Monit. 2016;21:171–7.

    Article  PubMed  Google Scholar 

  25. Tani S, Asayama K, Oiwa K, Harasawa S, Okubo K, Takahashi A, et al. The effects of increasing calcium channel blocker dose vs. adding a diuretic to treatment regimens for patients with uncontrolled hypertension. Hypertens Res. 2017;40:892–8.

    Article  CAS  PubMed  Google Scholar 

  26. Ushigome E, Matsumoto S, Oyabu C, Ushigome H, Yokota I, Hasegawa G, et al. Olmesartan with azelnidipine versus with trichlormethiazide on home blood pressure variability in patients with type II diabetes mellitus. J Am Soc Hypertens. 2017;11:140–7.

    Article  CAS  PubMed  Google Scholar 

  27. Kario K, Ishikawa J, Pickering TG, Hoshide S, Eguchi K, Morinari M, et al. Morning hypertension: the strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res. 2006;29:581–7.

    Article  PubMed  Google Scholar 

  28. Asayama K, Ohkubo T, Kikuya M, Obara T, Metoki H, Inoue R, et al. Prediction of stroke by home “morning” versus “evening” blood pressure values: the Ohasama study. Hypertension. 2006;48:737–43.

    Article  CAS  PubMed  Google Scholar 

  29. Guo QH, Cheng YB, Zhang DY, Wang Y, Huang QF, Sheng CS, et al. Comparison between home and ambulatory morning blood pressure and morning hypertension in their reproducibility and associations with vascular injury. Hypertension. 2019;74:137–44.

    Article  CAS  PubMed  Google Scholar 

  30. Kario K, Wang JG, Chia YC, Wang TD, Li Y, Siddique S, et al. The HOPE Asia network 2022 up-date consensus statement on morning hypertension management. J Clin Hypertens. 2022;24:1112–20.

    Article  Google Scholar 

  31. Liu J, Li Y, Asayama K, Zhang XJ, Cheng HM, Park S, et al. Asian expert consensus on nocturnal hypertension management. Hypertension. 2025;82:945–56.

    Article  CAS  PubMed  Google Scholar 

  32. Kario K, Hoshide S, Chia YC, Buranakitjaroen P, Siddique S, Shin J, et al. Guidance on ambulatory blood pressure monitoring: a statement from the HOPE Asia Network. J Clin Hypertens. 2021;23:411–21.

    Article  Google Scholar 

Download references

Acknowledgements

The authors gratefully acknowledge the voluntary participation of the patients and the contribution of the investigators from 20 hospitals and community health centers.

The ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD) investigators

Kai Zhao7, Yihong Luo8, Bing Deng9, Xin Chen10, Yinglong Qiu11, Mei-Ling Wang12, Zhihong Zhou13, Leijun Wang14, Jiahong Wang15, Ji-Guang Wang16, Yan Li16, Guibin He17, Hong Yu18, Ping Wang19, Yingmin Lu20, Yanping Zhang21, Yong Luo22, Jianhua Chen23, Min Liu24, Qing Peng25, and Jianqiang Xiao26

Funding

The study was partially funded by Di’ao Pharmaceuticals (Chengdu, Sichuan Province, China). The study investigators were also supported by the National Natural Science Foundation of China (grants 82370426, 82270469, 82070432, and 81970353), the Ministry of Science and Technology (2022YFC3601302 and 2024ZD0527304), Beijing, China, the Shanghai Municipal Health Commission (202340035 and 2024ZZ1028 and a Grant for Leading Academics 2022LJ022), and the Shanghai Talent Work Bureau (an Oriental Talent Program BJWS2024086).

Author information

Authors and Affiliations

Consortia

Corresponding author

Correspondence to Ji-Guang Wang.

Ethics declarations

Conflict of interest

JGW reports having received lecture and consulting fees from Novartis, Omron, Servier, and Viatris. The other authors declare no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, QF., Zhang, D., Luo, Y. et al. Antihypertensive treatment effect of two dual therapies according to sodium sensitivity. Hypertens Res 49, 340–349 (2026). https://doi.org/10.1038/s41440-025-02382-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41440-025-02382-x

Keywords

Search

Quick links